Ahmed v. Sebelius

710 F. Supp. 2d 167, 2010 U.S. Dist. LEXIS 45476, 2010 WL 1852132
CourtDistrict Court, D. Massachusetts
DecidedMay 10, 2010
DocketCivil Action 09-cv-11441-DPW
StatusPublished
Cited by5 cases

This text of 710 F. Supp. 2d 167 (Ahmed v. Sebelius) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ahmed v. Sebelius, 710 F. Supp. 2d 167, 2010 U.S. Dist. LEXIS 45476, 2010 WL 1852132 (D. Mass. 2010).

Opinion

MEMORANDUM AND ORDER

DOUGLAS P. WOODLOCK, District Judge.

Plaintiff-Petitioner Abdul Razzaque Ahmed, M.D. filed this action against DefendanNRespondent Kathleen Sebelius, the Secretary of the United States Department of Health and Human Services (the “Secretary”), seeking judicial review of a final decision by the Department of Health and Human Services (“HHS”) revoking his Medicare billing privileges. See 42 U.S.C. § 405(g). The decision, rendered by the Appellate Division of the Departmental Appeals Board (“DAB”), was based on Ahmed’s felony conviction for obstruction of a criminal investigation into health care offenses in violation of 18 U.S.C. § 1518. The Secretary, in support of this final decision, has filed a motion for judgment on the pleadings under Federal Rule of Civil Procedure 12(c), or in the alternative, for summary judgment under Rule 56. Ahmed, seeking to have the final decision reversed, has filed a cross-motion for judgment on the pleadings or for summary judgment. I will grant the Secretary’s motion.

I. BACKGROUND 1

Ahmed is a Massachusetts dermatologist who specializes in the diagnosis and treatment of autoimmune skin blistering dis *170 eases. Prior to the commencement of the administrative action in this case, Ahmed was an approved Medicare supplier, 2 treated Medicare patients, and received reimbursements from Medicare for those treatments.

A. The Medicare Program

The Medicare program provides health insurance benefits to individuals over age sixty-five and to certain disabled persons. Social Security Act § 1811, 42 U.S.C. § 1395c. Medicare is administered by the Centers for Medicare and Medicaid Services (“CMS”), an agency of HHS. Congress has granted the Secretary broad authority to issue regulations relating to the administration of Medicare pursuant to Sections 1102 and 1871 of the Social Security Act. See 42 U.S.C. § 1302(a) (authorizing the Secretary to “make and publish such rules and regulations ... as may be necessary to the efficient administration of the functions” of Medicare); id. at § 1395hh(a)(l) (“The Secretary shall prescribe such regulations as may be necessary to carry out the administration of the [Medicare] insurance programs.... ”). A physician wishing to participate in Medicare must first enroll in the program to receive Medicare billing privileges and a billing number. 42 C,F.R. §§ 424.500-.505.

To maintain billing privileges, physicians must complete the applicable enrollment application and revalidate their Medicare enrollment information every five years. 42 C.F.R. § 424.515. The application requires the physician to list any “final adverse actions” including any felony convictions. 3 CMS also may perform “off cycle revalidations.” 42 C.F.R. § 424.515(d).

In addition, CMS has regulatory authority to revoke a physician’s Medicare enrollment and billing privileges in certain instances. 42 C.F.R. § 424.535(a). Relevant to this case is the regulation permitting revocation if, “within the 10 years preceding enrollment or revalidation of enrollment,” the physician “was convicted of a Federal or State felony offense that CMS has determined to be detrimental to the best interests of the [Medicare] program and its beneficiaries.” § 424.535(a)(3).

B. Ahmed’s Criminal Activity

From 1997 through 2001, Ahmed’s medical practice focused on the treatment of pemphigus and pemphigoid, two autoimmune skin blistering diseases, using intravenous immunoglobulin (“IVIg”). This *171 treatment markedly improved — and even saved — the lives of many of Ahmed’s patients. However, during that period, Medicare authorized coverage of IVIg treatment only for pemphigus and denied coverage for pemphigoid. 4 In early 2000, Medicare noticed that it had been paying Ahmed millions of dollars for IVIg treatments, and that many of his Medicare coverage claims cited “dual diagnoses” of pemphigus and pemphigoid. The United States Attorney for the District of Massachusetts commenced an investigation to determine whether these diagnoses were fraudulent.

In June 2000, Ahmed was served with a subpoena for medical records of the patients whom he had treated with IVIg. In response, Ahmed produced ninety-four patient files, some of which he improperly supplemented with backdated documents, including correspondence and immunopathology reports that falsely diagnosed the patients with both diseases. Ultimately, Ahmed was charged criminally in a fifteen count superceding indictment, including charges of mail fraud, health care fraud, obstruction of a criminal investigation of health care offenses, and money laundering. On November 5, 2007, Ahmed entered into a plea agreement with the United States pursuant to which he pled guilty to Count 12, which charged obstruction of a criminal investigation of a health care offense under 18 U.S.C. § 1518; 5 the remaining charges were dismissed.

During the plea colloquy, the prosecutor recited certain evidence that would have been adduced had the case gone to trial:

[T]he defendant produced medical records for approximately 94 patients whom he had treated with IVIg. Many of these medical records were for patients who were Medicare insureds. At trial, the government would have proven that the medical files produced by the defendant contained false backdated documents that had been created to falsely suggest that patients suffering from pemphigoid, the disease not covered by Medicare, were also suffering from pemphigus, the disease covered by Medicare for IVIg treatments.
For example, certain medical files produced by the defendant contained documents entitled immunopathology report signed by the defendant. These reports purported to show that on a certain date the defendant had performed a blood sera test in which he had found the patient had pemphigus. The evidence at trial would be that such a test had not been done and that the immunopathology report had been falsified and backdated.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

LILIA GOROVITS, M.D., P.C. v. AZAR
E.D. Pennsylvania, 2021
Morgan v. Azar
S.D. West Virginia, 2020
AAA Pharmacy, Inc. v. United States
108 Fed. Cl. 321 (Federal Claims, 2012)
Fayad v. Sebelius
803 F. Supp. 2d 699 (E.D. Michigan, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
710 F. Supp. 2d 167, 2010 U.S. Dist. LEXIS 45476, 2010 WL 1852132, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ahmed-v-sebelius-mad-2010.